History is being made in the latest epidemic of Ebola virus
infection - Vaccine to be used in DRCONGO ---
'How many doses of vaccine have arrived so far to the DRC,
and how many more can GAVI support?
On the ground now are 4,320 doses and another 5,400 doses
are moving towards there. That means within a few days we should have more than
9,000 in the DRC. When we did our advance purchase commitment with Merck they
were required to have 300,000 doses available, so there are obviously more
doses that we can move forward if necessary.
This experimental vaccine can only be used in the context of
a clinical trial. Can you talk a bit about that?
This vaccine—and only this vaccine—has been through efficacy
trials in humans and there it showed 100 percent efficacy protecting against
Ebola. But the point is that it has gone through all of those procedures and is
now being prepared for licensure. In a sense it is an experimental vaccine
because it is not yet licensed—but you also need to keep in mind that it is a
vaccine that has gone through safety and efficacy testing already. This
clinical trial will provide more data on safety and efficacy, and will be done
under informed consent using good clinical practices.
Africa Center for
Clin Gov Research & Patient Safety
@ HRI West Africa Group - HRI WA
Consultants in Clinical Governance Implementation
Publisher: Health and Medical Journals
8 Amaku Street Housing Estate, Calabar
Cross River State, Nigeria
Cross River State, Nigeria
Phone No. +234 (0) 8063600642
Joseph Ana has a cumulative continuous practice experience of over 40-years in
Nigeria, United Kingdom and Ghana as a Primary Health Care Physician, Public
Health Expert, General and Urological Surgeon, Health Policy Expert and
Implementer, Medical Educator and Trainer..
Socialize